High-Throughput Approaches to the Development of Molecular Imaging Agents

Lina Y. Hu, Kimberly A. Kelly, Julie Sutcliffe

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Molecular imaging allows for the visualization of changes at the cellular level in diseases such as cancer. A successful molecular imaging agent must rely on disease-selective targets and ligands that specifically interact with those targets. Unfortunately, the translation of novel target-specific ligands into the clinic has been frustratingly slow with limitations including the complex design and screening approaches for ligand identification, as well as their subsequent optimization into useful imaging agents. This review focuses on combinatorial library approaches towards addressing these two challenges, with particular focus on phage display and one-bead one-compound (OBOC) libraries. Both of these peptide-based techniques have proven successful in identifying new ligands for cancer-specific targets and some of the success stories will be highlighted. New developments in screening methodology and sequencing technology have pushed the bounds of phage display and OBOC even further, allowing for even faster and more robust discovery of novel ligands. The combination of multiple high-throughput technologies will not only allow for more accurate identification, but also faster affinity maturation, while overall streamlining the process of translating novel ligands into clinical imaging agents.

Original languageEnglish (US)
Pages (from-to)1-20
Number of pages20
JournalMolecular Imaging and Biology
DOIs
StateAccepted/In press - Nov 3 2016

Fingerprint

Molecular Imaging
Ligands
Bacteriophages
Technology
Libraries
Neoplasms
Peptides

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

High-Throughput Approaches to the Development of Molecular Imaging Agents. / Hu, Lina Y.; Kelly, Kimberly A.; Sutcliffe, Julie.

In: Molecular Imaging and Biology, 03.11.2016, p. 1-20.

Research output: Contribution to journalArticle

@article{8af9892825694e7497efc8d41d31c5b6,
title = "High-Throughput Approaches to the Development of Molecular Imaging Agents",
abstract = "Molecular imaging allows for the visualization of changes at the cellular level in diseases such as cancer. A successful molecular imaging agent must rely on disease-selective targets and ligands that specifically interact with those targets. Unfortunately, the translation of novel target-specific ligands into the clinic has been frustratingly slow with limitations including the complex design and screening approaches for ligand identification, as well as their subsequent optimization into useful imaging agents. This review focuses on combinatorial library approaches towards addressing these two challenges, with particular focus on phage display and one-bead one-compound (OBOC) libraries. Both of these peptide-based techniques have proven successful in identifying new ligands for cancer-specific targets and some of the success stories will be highlighted. New developments in screening methodology and sequencing technology have pushed the bounds of phage display and OBOC even further, allowing for even faster and more robust discovery of novel ligands. The combination of multiple high-throughput technologies will not only allow for more accurate identification, but also faster affinity maturation, while overall streamlining the process of translating novel ligands into clinical imaging agents.",
author = "Hu, {Lina Y.} and Kelly, {Kimberly A.} and Julie Sutcliffe",
year = "2016",
month = "11",
day = "3",
doi = "10.1007/s11307-016-1016-z",
language = "English (US)",
pages = "1--20",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer New York",

}

TY - JOUR

T1 - High-Throughput Approaches to the Development of Molecular Imaging Agents

AU - Hu, Lina Y.

AU - Kelly, Kimberly A.

AU - Sutcliffe, Julie

PY - 2016/11/3

Y1 - 2016/11/3

N2 - Molecular imaging allows for the visualization of changes at the cellular level in diseases such as cancer. A successful molecular imaging agent must rely on disease-selective targets and ligands that specifically interact with those targets. Unfortunately, the translation of novel target-specific ligands into the clinic has been frustratingly slow with limitations including the complex design and screening approaches for ligand identification, as well as their subsequent optimization into useful imaging agents. This review focuses on combinatorial library approaches towards addressing these two challenges, with particular focus on phage display and one-bead one-compound (OBOC) libraries. Both of these peptide-based techniques have proven successful in identifying new ligands for cancer-specific targets and some of the success stories will be highlighted. New developments in screening methodology and sequencing technology have pushed the bounds of phage display and OBOC even further, allowing for even faster and more robust discovery of novel ligands. The combination of multiple high-throughput technologies will not only allow for more accurate identification, but also faster affinity maturation, while overall streamlining the process of translating novel ligands into clinical imaging agents.

AB - Molecular imaging allows for the visualization of changes at the cellular level in diseases such as cancer. A successful molecular imaging agent must rely on disease-selective targets and ligands that specifically interact with those targets. Unfortunately, the translation of novel target-specific ligands into the clinic has been frustratingly slow with limitations including the complex design and screening approaches for ligand identification, as well as their subsequent optimization into useful imaging agents. This review focuses on combinatorial library approaches towards addressing these two challenges, with particular focus on phage display and one-bead one-compound (OBOC) libraries. Both of these peptide-based techniques have proven successful in identifying new ligands for cancer-specific targets and some of the success stories will be highlighted. New developments in screening methodology and sequencing technology have pushed the bounds of phage display and OBOC even further, allowing for even faster and more robust discovery of novel ligands. The combination of multiple high-throughput technologies will not only allow for more accurate identification, but also faster affinity maturation, while overall streamlining the process of translating novel ligands into clinical imaging agents.

UR - http://www.scopus.com/inward/record.url?scp=84994332545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994332545&partnerID=8YFLogxK

U2 - 10.1007/s11307-016-1016-z

DO - 10.1007/s11307-016-1016-z

M3 - Article

SP - 1

EP - 20

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

ER -